Allegro Raises $4.5M to Support Commercialization of Lung Cancer Test

The funds were raised in a Series A extension financing and will go toward the commercialization of its BronchoGen test in 2012.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories